The influence of drug class on reward in substance use disorders

• Published in: Pharmacology, biochemistry and behavior biochemistry and behavior, 2024-07, Vol.240, p.173771-173771, Article 173771
• Main Authors: Jones, Jermaine D., Arout, Caroline A., Luba, Rachel, Murugesan, Dillon, Madera, Gabriela, Gorsuch, Liam, Schusterman, Rebecca, Martinez, Suky
• Format: Article
• Language: English
• ISSN: 0091-3057; 1873-5177
• DOI: 10.1016/j.pbb.2024.173771

In the United States, the societal costs associated with drug use surpass $500 billion annually. The rewarding and reinforcing properties that drive the use of these addictive substances are typically examined concerning the neurobiological effects responsible for their abuse potential. In this review, terms such as “abuse potential,” “drug,” and “addictive properties” are used due to their relevance to the methodological, theoretical, and conceptual framework for understanding the phenomenon of drug-taking behavior and the associated body of preclinical and clinical literature. The use of these terms is not intended to cast aspersions on individuals with substance use disorders (SUD). Understanding what motivates substance use has been a focus of SUD research for decades. Much of this corpus of work has focused on the shared effects of each drug class to increase dopaminergic transmission within the central reward pathways of the brain, or the “reward center.” However, the precise influence of each drug class on dopamine signaling, and the extent thereof, differs considerably. Furthermore, the aforementioned substances have effects on several neurobiological targets that mediate and modulate their addictive properties. The current manuscript sought to review the influence of drug class on the rewarding effects of each of the major pharmacological classes of addictive drugs (i.e., psychostimulants, opioids, nicotine, alcohol, and cannabinoids). Our review suggests that even subtle differences in drug effects can result in significant variability in the subjective experience of the drug, altering rewarding and other reinforcing effects. Additionally, this review will argue that reward (i.e., the attractive and motivational property of a stimulus) alone is not sufficient to explain the abuse liability of these substances. Instead, abuse potential is best examined as a function of both positive and negative reinforcing drug effects (i.e., stimuli that the subject will work to attain and stimuli that the subject will work to end or avoid, respectively). Though reward is central to drug use, the factors that motivate and maintain drug taking are varied and complex, with much to be elucidated. •The manuscript reviews the influence of drug class on the rewarding effects of each of the major classes of addictive drugs.•Subtle differences in drug effects can result in significant variability in the subjective experience of the drug.•Reward (i.e., the attractive and